Skip to content

About mCRC Liver Cancer

Treating mCRC Liver Tumors

It is important to find liver tumors early because it is in the early stage that they are curable.

Surgery, radiation therapy, chemotherapy and biological therapy are the major treatments for liver tumors. These treatments do have limitations.

Local-regional procedures such as SIRT (selective internal radiation therapy) may complement this spectrum of treatment options.


surgery
  • Surgery

  • Surgery is an important part of controlling the spread of cancer in the liver. However, only a few patients may benefit from undergoing surgery. This may be due to the location of the tumor(s) in their liver or the patients’ health status.
  • For a transplantation, the patient must meet the criteria, and a donor organ needs to be available.

diagnostic
  • Radiation therapy

  • Radiation is an effective way to destroy tumor tissues and is used widely in cancer treatment.
  • However, all types of organs and tissues in the body are sensitive to radiation, and the healthy ones may also be damaged by radiation treatment.

drugs
  • Drugs

  • Drugs, such as chemotherapy or biological therapy, keep the cancer cells from growing and multiplying.
  • Drugs often become less effective over time and repeated use.
  • Some types of cancer do not respond well to drugs.

liver
  • Local-Regional Treatments

  • Local regional procedures are minimally invasive treatments. They target the tumor(s) in the liver directly.
  • Various treatment types exist. Some use chemotherapy, heat, cold or radiation.

Caution: Federal (USA) law restricts this device to sale by or on the order of a physician Indications for Use: SIR-Spheres® Y-90 resin microspheres are indicated for the local tumor control of unresectable hepatocellular carcinoma (HCC) in patients with no macrovascular invasion, Child Pugh-A cirrhosis, well-compensated liver function, and good performance status. They are also indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine). Side Effects: Common side effects are fever, transient decrease of hemoglobin, mild to moderate abnormality of liver function tests, abdominal pain, nausea, vomiting, and diarrhea. Potential serious effects due to exposure to high radiation include acute pancreatitis, radiation pneumonitis, acute gastritis, acute cholecystitis and radioembolization induced liver disease (REILD). Consult the Instructions for Use for a complete listing of indications, contraindications, side effects, warnings, and precautions.